Lixte Biotechnology
LIXT
LIXT
12 hedge funds and large institutions have $1.49M invested in Lixte Biotechnology in 2022 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 4 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
50% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 4
Holders
12
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$31K | |
| 2 | +$24K | |
| 3 | +$8.28K | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$371 |
Top Sellers
| 1 | -$43K | |
| 2 | -$17K | |
| 3 | -$1.05K | |
| 4 |
BlackRock
New York
|
-$816 |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$234 |